SEC Form 3 · accession 0000919574-15-004978
ALPINE IMMUNE SCIENCES, INC. · ALPN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Jun 16, 2015
Accepted (ET)
Jun 18, 2015 · 3:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001626199
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 650,915 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The securities are held in the account of Tiger Partners, L.P. and may be deemed to be beneficially owned by (a) Tiger Management L.L.C., the investment manager of Tiger Partners, L.P., and (b) Tiger Partners GP, LLC, the general partner of Tiger Partners, L.P. Each of Tiger Partners, L.P., Tiger Management L.L.C. and Tiger Partners GP, LLC disclaims beneficial ownership of these reported securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that any such person is the beneficial owner of these securities for purposes of Section 16 of the U.S. Securities Exchange Act of 1934, as amended, or for any other purpose.